← SynDRA
QUININE
SynDRA canonical compound SYN0005133 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | KCNN4 |
|---|
| Mechanism of action | Hemozoin biocrystallization inhibitor |
|---|
| Indication | malaria |
|---|
| Disease area | infectious disease |
|---|
All known targets
- KCNB2
- KCNN4
- SLC29A4
- ABCB1
- GP9
- HBA1
- KCNH2
- SCN1A
- SCN2A
- SCN3A
- SLC22A1
Mechanisms of action (all sources)
- Hemozoin biocrystallization inhibitor
Drug classes
- Antimalarial
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Infective Agents
- Antimalarials
- Antiparasitic Agents
- Antiprotozoal Agents
- Central Nervous System Agents
- Muscle Relaxants, Central
- Neuromuscular Agents
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- M09A · OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
- P01B · ANTIMALARIALS
Cross-references
Synonyms
- quinine bisulfate heptahydrate
- chinine
- qualaquin
- quinine sulfate
- (8s,9r)-6'-methoxycinchonan-9-ol
- Chininum purum
- Rezquin
- NSC-192949
- WR297608
- Aflukin
- Chinin
- Chinine
- Chininum
- Conchinin
- Conquinine
- Quindan
- Quinidex
- Quinidine
- Quinimax
- Quinina
- Quinineanhydrous
- Quinora
- Quniacridine
- Chinin [German]
- Kinder Quinina
- QUININE MONO HCL
- Quinine Dab
- Quinine [BAN]
- Quinine anhydrous
- Quinine bisulfate
- Quinine sulfate
- Quinine sulphate
- Quinoline alkaloid
- LT00645788;Q0028
- SB01652
- Beta-Quinine
- Cin-Quin
- Coco-Quinine
Reported adverse events
- Chronic renal impairment
- Stevens-Johnson syndrome
Look up QUININE in the interactive SynDRA portal →